Preclinical (premotor) Parkinson's disease

Journal of Neurology, Supplement

Volumn 247, Issue 2, 2000, Pages 103-109

  Wolters, Erik C ^a   Francot, Chantal ^a   Bergmans, Paul ^a   Winogrodzka, Ania ^a   Booij, Jan ^a   Berendse, Henk W ^a   Stoof, Johannes C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hyposmia; Olfaction; Parkinson's disease; Smell; 123I CIT SPECT

Indexed keywords

DOPA; FLUORINE 18;

ADULT; AGED; BRAIN STEM; CONFERENCE PAPER; DISEASE COURSE; DISEASE PREDISPOSITION; DOPAMINERGIC SYSTEM; EARLY DIAGNOSIS; FEMALE; HUMAN; MALE; MOOD; NEUROLOGIC DISEASE; NEUROPROTECTION; NORMAL HUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PERSONALITY DISORDER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCREENING TEST; SENSORIMOTOR FUNCTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMELLING;

HUMANS; OLFACTION DISORDERS; PARKINSON DISEASE;

EID: 0034102381     PISSN: 09391517     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Asenbaum S, Brücke T, Pirker W, Podreka J, Angelberger D, Wenger S, Wober C, Muller C, Deecke L (1997) Imaging of dopamine transporters with iodine-123-β-CIT and SPECT in Parkinson's Disease. J Nucl Med 38: 1-6
2. Benecke R, Rothwell JC, Dick JP, Day BL, Marsden CD (1987) Disturbance of sequential movements in patients with Parkinson's disease. Brain 110:361-379
3. 123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 62:133-140
4. Brooks DJ (1998) The early diagnosis of Parkinson's disease. Ann Neurol 44 (Suppl 1):S 10-S 18
5. Brown RG, Marsden CD (1988) Internal versus external cues and the control of attention in Parkinson's disease. Brain 111:323-345
6. Brown RG, Marsden CD (1990) Cognitive function in Parkinson's disease: From description to theory. Trends Neurosci 13:21-29
7. Brown RG, Soliveri P, Jahanshahi M (1998) Executive processes in Parkinson's disease - random number generation and response suppression. Neuropsychol 36: 1355-1362
8. 123I]β-CIT. Binding kinetics in the human brain. J Neural Transm (GenSect) 94: 137-146
9. Cools AR, Berger HJC, Buytenhuijs EL, Horstink MWIM, van Spaendonck KPM (1993) Manifestations of switching disorders in animals and man with dopamine deficits in A10 and/or A9 circuitries. In: Wolters ECh, Scheltens Ph (eds) Mental dysfunction in Parkinson's disease. ICG, Dordrecht, pp 49-69
10. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV (1991) Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 114:2095-2122
11. Cummings JL (1992) Depression and Parkinson's disease: A review. Am J Psychiatry 149:443-454
12. Doty RL (1997) Review. Studies of human olfaction from the University of Pennsylvania Smell and Taste Center. Chem Senses 22:565-586
13. Doty RL, Bromley SM, Stern MB (1995) Olfactory testing as an aid in the diagnosis of Parkinson's disease: Development of optimal discrimination criteria. Neurodegeneration 4:93-97
14. Doty RL, Deems DA, Stellar S (1988). Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237-1244
15. Doty RL, Golbe LKI, McKeown DA, Stern MB, Lehrach CM, Crawford D (1993). Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology 43:962-965
16. Doty RL, Marcus A, Lee W (1996) Development of the 12-item cross-cultural smell-identification test (CC-SIT). Laryngoscope 106:353-356
17. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 55:138-142
18. Dubois B, Pillon B (1997) Cognitive deficits in Parkinson's disease. J Neurol 244:2-8
19. Ebersbach G, Hattig H, Schelosky L, Wissel J, Poewe W (1994) Perseverative motor behaviour in Parkinson's disease. Neuropsychologia 32:799-804
20. Folstein MF, Folstein SF, McHugh PR (1975) 'Mini Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
21. Gabrieli JDE, Singh J, Stebbins GT, Goetz CG (1996) Reduced working memory span in Parkinson's disease: Evidence for the role of a frontostriatal system in working and strategic memory. Neuropsychology 10:322-332
22. Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 62:436-446
23. Hirsch EC, Hunot S, Damier P, Faucheux B (1998) Glial cells and inflammation in Parkinson's disease: A role in neurodegeneration? Ann Neurol 44 (Suppl 1):S 115-S 120
24. Hocherman S, Aharon-Peretz J (1994) Two-dimensional tracing and tracking in patients with Parkinson's disease. Neurology 44: 111-116
25. Hocherman S, Giladi N (1998) Visuomotor control abnormalities in patients with unilateral parkinsonism. Neurology 50:1648-1654
26. Hoogendijk WJG, Sommer IEC, Tissingh G, Deeg DJH, Wolters ECh (1998) Depression in Parkinson's disease: The impact of symptom overlap on prevalence. Psychosomatics 39: 416-421
27. Huber SJ, Freidenberg DL, Paulson GW, Shuttleworth EC, Christy JA (1990) The pattern of depressive symptoms varies with progression of Parkinson's disease. J Neurol Neurosurg Psychiatry 53:275-278
28. Innis RB, Seibyl JP, Scanley BE, Laruelle M, Abi-Dargham A, Wallace E, Baldwin RM, Zea-Ponce Y, Zoghbi S, Wang S, Gao Y, Wallace E, Baldwin RM, Neumeyer JL, Charney DS, Hoffer PB, Marek KL (1993) Single-photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson's disease. Proc Nail Acad Sci USA 90: 11965-11969
29. Jenner P, Olanow W (1998) Understanding cell death in Parkinson's disease. Ann Neurol 44 (Suppl 1):S 72-S 84
30. Kitada T, Asakawa S, Hattori N, Mutsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the Parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-608
31. Koller WC (1998) Neuroprotection for Parkinson's disease. Ann Neurol 44(Suppl I):S 155-S 159
32. 123I]β-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab 14:982-994
33. Lindeboom J, Ter Horst R, Hooyer C, Dinkgreve M, Jonker C (1993) Some psychometric properties of the CAMCOG. Psychol Med 3:213-219
34. Luteijn F, Starren J, van Dijk H (1975) Handleiding bij de NPV. Swets & Zeitlinger Lisse
35. Marder K, Tang MX, Mejia H. Alfaro BA, Cote L, Louis E, Groves J, Mayeux R (1996) Risk of Parkinson's disease among first degree relatives. Neurology 47: 155-160
36. 123M]β-CIT: Assessment of progression in Parkinson's disease. Neurology 48 (Suppl 2): A207
37. 123I]β-CIT SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology 46:231-237
38. Markopoulou K, Larsen KW, Wszolek EK Denson MA, Lang AE, Pfeiffer RF, Wszolek ZK (1997) Olfactory dysfunction in familial parkinsonism. Neurology 49:1262-1267
39. Marsden CW, Olanow CW (1998) The causes of Parkinson's disease are being unravelled and rational neuroprotective therapy is close to reality. Ann Neurol 44 (Suppl 1):S 189-S 196
40. Mesholam RI, Moberg PJ, Mahr RN, Doty RL (1998) Olfaction in neurodegenerative disease. A meta analysis of olfactory functioning in Alzheimer's and Parkinson's diseases. Arch Neurol 55:84-90
41. Milner B (1971) Interhemispheric differences in the localisation of psychological processes in man. Br Med Bull 27:272-277
42. Mittenecker E (1958) Die analyse 'zufälliger' Reaktionsfolgen. Z Exp Angew Psychol 5:45-60
43. Moll B, Klimek L, Eggers G, Mann W (1998) Comparison of olfactory function in patients with seasonal and perennial allergic rhinitis. Allergy 53: 297-301
44. Montgomery EB, Baker KB, Lyons K, Koller WC (1999) Abnormal performance on the PD test buttery by asymptomatic first degree relatives. Neurology 52:757-762
45. Morris RG, Downes JJ, Sahakian BJ, Evenden JL, Heald A, Robbins TW (1988) Planning and spatial working memory in Parkinson's disease. J Neurol Neurosurg Psychiatry 51:757-766
46. Morrish PK, Rakshi JS, Sawle GV, Brooks DJ (1998) Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with 18-F-dopa PET. J Neurol Neurosurg Psychiatry 64:314-319
47. Payami H, Larsen K, Bernard S. Nutt J (1994) Increased risk of Parkinson's disease in parents and siblings of patients. Arch Neurol 36:659-661
48. Petrides M, Milner B (1982) Deficits on subject-ordered tasks after frontal and temporal lobe lesions in man. Neuropsychologia 20:249-262
49. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehijia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoison RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047
50. 123I]β-CIT SPECT. Parkinson Related Disord 1:47-51
51. Rossor MN, Marsden CD (1987) Ol-factory threshold in Parkinson's disease. J Neurol Neurosurg Psychiatry 50:88-89
52. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R (1986) CAMDEX: A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149:698-709
53. 123M]β-CIT striatal uptake correlates with symptom severity in Parkinson's disease. Ann Neurol 38:589-598
54. Schneider JS, Pope-Coleman A (1995) Cognitive deficits precede motor deficits in a slowly progressing model of parkinsonism in the monkey. Neurodegeneration 4:245-255
55. Stern MB, Doty RL, Dotti M, Corcoran P, Crawford D, McKeown DA, Adler C. Gollomp S, Hurtig H (1994) Olfactory function in Parkinson's disease subtypes. Neurology 44:266-268
56. Tandberg E, Larsen JP, Aarsland D, Cummings JL (1996) The occurrence of depression in Parkinson's disease. Arch Neurol 53: 175-179
57. Tatton NA, Maclean-Fraser A, Tatton WG, Perl DP, Olanow CW (1998) The fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann Neurol 44 (Suppl 1):S 142-148
58. 123I]β-CIT SPECT. J Neurol 245:14-20
59. Tissingh G, Bergmans P, Winogrodzka A. Drukarch B, Stoof JC, Wolters ECh (1999) Reduced olfactory dysfunction in Parkinson's disease. Mov Disord (in press)
60. Todes CJ, Lees AJ (1985) The premorbid personality of patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 48:97-100
61. 123I]β-CIT binding with SPECT in controls, early and late Parkinson's disease. Nucl Med Biol 22:985-991
62. Ward CD, Hess WA, Calne DB (1983) Olfactory impairment in Parkinson's disease. Neurology 33:943-946
63. Wechsler D (1987) Wechsler Memory Scale-Revised Manual. The Psychol Corp, San Antonio TX
64. Wenning GK, Shephard B, Hawkes C, Petruckevitch, Lees A, Quinn N (1995) Olfactory function in atypical parkinsonian syndromes. Acta Neural Scand 91:247-250
65. Wiegersma S, Van der Scheer E, Hijman R (1990) Subjective ordering, short term memory and the frontal lobes. Neuropsychologia 28:95-98
66. 123I]β-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early stage Parkinson's disease. Parkinsonism Rel Disord 5(S2):39-40
67. Wolters ECh, Francot CMJE (1998) Mental dysfunction in Parkinson's disease. Parkinson Related disord 4:107-112